Overview

Over the last years, due to intensive competition in the knowledge economy, legal aspects surrounding intellectual property (IP) rights - including litigation and settlement - have continuously gained in importance. Correspondingly, professional IP management has become an indispensable element of successful value-based management (VBM) in research-intensive firms. With this text, the author proposes an integrated approach to patent risk and capital budgeting in pharmaceutical research and development (R and D), developing an option-based view (OBV) of imperfect patent protection, which draws upon contingent-claims analysis, stochastic game theory, as well as novel numerical methods. Bridging a widening gap between recent advances in the theory of financial analysis and current challenges faced by pharmaceutical companies, the text re-initiates a discussion about the contribution of quantitative frameworks to value-based R and D management.

Full Product Details

Author:   Philipp N. Baecker
Publisher:   Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
Imprint:   Springer-Verlag Berlin and Heidelberg GmbH & Co. K
Edition:   2007 ed.
Volume:   587
Dimensions:   Width: 15.50cm , Height: 1.50cm , Length: 23.50cm
Weight:   0.910kg
ISBN:  

9783540482635

ISBN 10:   3540482636
Pages:   282
Publication Date:   10 January 2007
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   In Print  
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

Patenting Under Uncertainty.- Patent Protection, the Firm, and the Economy.- Uncertainty, Irreversibility, and Flexibility.- Patent Protection in the Pharmaceutical Industry.- Exogenous Patent Risk.- and Related Work.- Patents as Investment Opportunities.- Patent Risk as Jumps in the Underlying Process.- From Business Shifts to Jump Processes.- Preliminary Conclusion.- Endogenous Patent Risk.- and Related Work.- Patent Risk as an Option to Litigate.- Preliminary Conclusion.- Conclusion.

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions